Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 4 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).